Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 24028306)

1.

Hypertension management algorithm for type 2 diabetic patients applied in primary care.

Viana LV, Leitão CB, Grillo MF, Rocha EP, Brenner JK, Friedman R, Gross JL.

Diabetol Metab Syndr. 2013 Sep 12;5(1):52. doi: 10.1186/1758-5996-5-52.

2.
3.

Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study.

de la Sierra A, Roca-Cusachs A, Redón J, Marín R, Luque M, de la Figuera M, Garcia-Garcia M, Falkon L; CENIT Study Working Group.

Clin Drug Investig. 2009;29(7):459-69. doi: 10.2165/00044011-200929070-00004.

PMID:
19499963
4.

Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.

Akram J, Sheikh UE, Mahmood M, Donnelly R.

Curr Med Res Opin. 2007 Dec;23(12):2929-36.

PMID:
17931463
5.

Evaluating the treatment of hypertension in diabetes mellitus: a need for better control?

Sequeira RP, Al Khaja KA, Damanhori AH.

J Eval Clin Pract. 2004 Feb;10(1):107-16.

PMID:
14731158
6.

Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.

Barrios V, Brommer P, Haag U, Calderón A, Escobar C.

Clin Drug Investig. 2009;29(7):427-39. doi: 10.2165/00044011-200929070-00001.

PMID:
19499960
7.
8.

Antihypertensive efficacy of perindopril 5-10 mg/day in primary health care: an open-label, prospective, observational study.

Ionescu DD; PREFER Investigators.

Clin Drug Investig. 2009;29(12):767-76. doi: 10.2165/11319700-000000000-00000.

PMID:
19888783
9.

Current status of antihypertensive prescription and associated blood pressure control in Japan.

Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.

Hypertens Res. 2006 Mar;29(3):143-51.

PMID:
16755149
10.

New treatment guidelines for a patient with diabetes and hypertension.

Mogensen CE.

J Hypertens Suppl. 2003 Mar;21(1):S25-30. Review.

PMID:
12769164
11.

Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.

Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.

Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. Epub 2005 Oct 20.

PMID:
16487914
12.

Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.

Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M.

Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.

14.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

15.
16.

Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.

Ishikawa J, Kario K, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K; J-MORE Group.

Hypertens Res. 2006 Sep;29(9):679-86. Erratum in: Hypertens Res. 2007 Feb;30(2):203.

PMID:
17249523
17.

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: rationale, design, and methods.

Fukui T, Rahman M, Hayashi K, Takeda K, Higaki J, Sato T, Fukushima M, Sakamoto J, Morita S, Ogihara T, Fukiyama K, Fujishima M, Saruta T; CASE-J Study Group.

Hypertens Res. 2003 Dec;26(12):979-90. Review.

18.

ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.

Morgan TO, Anderson AI, MacInnis RJ.

Am J Hypertens. 2001 Mar;14(3):241-7.

PMID:
11281235
19.
20.

[Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].

Lou LM, Gimeno JA, Gómez Sánchez R, Labrador T, Beguer P, Lou MT, Boned B, Aguilar E.

Nefrologia. 2002;22(2):179-89. Spanish.

PMID:
12085419
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk